Father-Focused Intervention for Reducing Family Violence and Symptoms in Children

Description

The goal of this clinical trial is to test the efficacy of Fathers for Change (F4C) compared to standard Batterer Intervention for fathers with a history of Intimate Partner Violence. The main question\[s\] it aims to answer are: 1. Is F4C more efficacious than standard BIP in reducing family violence and child mental health impairment? 2. What are the trajectories of therapeutic change targets across interventions? 3. Does father's emotion regulation and reflective functioning mediate the relationship between the two interventions and child-related outcomes? Participants will be randomized to either Fathers for Change on Batterer Intervention.

Conditions

Intimate Partner Violence, Child Maltreatment

Talk to us

Study Overview

On this page

Study Details

Study overview

The goal of this clinical trial is to test the efficacy of Fathers for Change (F4C) compared to standard Batterer Intervention for fathers with a history of Intimate Partner Violence. The main question\[s\] it aims to answer are: 1. Is F4C more efficacious than standard BIP in reducing family violence and child mental health impairment? 2. What are the trajectories of therapeutic change targets across interventions? 3. Does father's emotion regulation and reflective functioning mediate the relationship between the two interventions and child-related outcomes? Participants will be randomized to either Fathers for Change on Batterer Intervention.

Examining Therapeutic Change Mechanisms in an Affect Regulation, Father-Focused Intervention for Reducing Family Violence and Associated Symptoms in Children

Father-Focused Intervention for Reducing Family Violence and Symptoms in Children

Condition
Intimate Partner Violence
Intervention / Treatment

-

Contacts and Locations

New Haven

Yale, New Haven, Connecticut, United States, 06520

West Hartford

UCONN Health Center, West Hartford, Connecticut, United States, 06119

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * have at least one 6 month to 12-year-old biological child with whom they have contact;
  • * had an incident of IPV within the last 12 months prior to screening with their child's mother (based on court/police records, coparent or self-report);
  • * have a currently open or recently investigated (in the last 6 months) case with CT DCF
  • * are able to complete assessments in English;
  • * agree to have their female coparents (mother of target child) contacted as collateral informants and for consent for participation of their child. If a participant has more than one child in the age range, the youngest will be selected;
  • * female coparents (i.e., biological mother who need not be in a relationship with the father) consents to (at minimum) provide parent-report on child; however, may opt out of child participation. If the coparent agrees to participate by providing caregiver-report on child symptoms, but declines participation of their shared child, the father may still participate in the study if he meets eligibility criteria outlined below; thus, preventing any possible retaliation against co-parents for not consenting to child participation.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Yale University,

Carla S Stover, PhD, PRINCIPAL_INVESTIGATOR, Yale University

Study Record Dates

2028-12-31